Drugmakers must do more to ensure access to treatments for antimicrobial-resistant superbugs, but GlaxoSmithKline and Johnson & Johnson are doing more than other organizations on 16 metrics of progress, according…
The Food and Drug Administration teamed up with the Federal Trade Commission to issue joint warning letters to 11 marketers and distributors of opioid cessation products, for illegally marketing products…
A federal circuit court upheld a PTO Patent Trial and Appeal Board ruling that a Johnson & Johnson patent for Remicade, which earned the company nearly $7 billion in 2016,…
The Senate voted 55 to 43 on Wednesday to confirm former pharmaceutical industry executive Alex Azar as HHS secretary. Source: Drug Industry Daily
But for now, the world’s biggest healthcare company isn’t providing many details on how it may use the extra money from lower tax rates. Source: BioSpace
This acquisition strategy is part of its two-pronged approach to growth, along with internal R&D. Source: BioSpace
Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved. Source: BioSpace
Here are five possible acquisition targets to keep an eye on. Source: BioSpace
Headquartered in South San Francisco, Surrozen focuses on developing drugs by leveraging insights into the Wnt signaling pathway. Source: BioSpace
Significant risk remains for companies that cannot move quickly enough to positively impact R&D productivity and for those that encounter challenges in accessing technology and expertise that likely lie outside…